Sihuan Pharmaceutical Holdings Group Ltd.
SHPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,901 | $1,861 | $2,181 | $3,038 |
| % Growth | 2.2% | -14.7% | -28.2% | – |
| Cost of Goods Sold | $659 | $565 | $694 | $608 |
| Gross Profit | $1,242 | $1,296 | $1,488 | $2,430 |
| % Margin | 65.3% | 69.6% | 68.2% | 80% |
| R&D Expenses | $474 | $592 | $1,085 | $868 |
| G&A Expenses | $745 | $469 | $552 | $592 |
| SG&A Expenses | $1,175 | $911 | $1,023 | $1,129 |
| Sales & Mktg Exp. | $430 | $442 | $471 | $537 |
| Other Operating Expenses | -$270 | -$369 | $1,210 | -$338 |
| Operating Expenses | $1,380 | $1,134 | $3,318 | $1,659 |
| Operating Income | -$138 | $162 | -$1,831 | $772 |
| % Margin | -7.3% | 8.7% | -83.9% | 25.4% |
| Other Income/Exp. Net | -$290 | -$323 | -$292 | -$276 |
| Pre-Tax Income | -$428 | -$161 | -$2,123 | $496 |
| Tax Expense | $43 | $96 | $197 | $253 |
| Net Income | -$217 | -$54 | -$1,915 | $417 |
| % Margin | -11.4% | -2.9% | -87.8% | 13.7% |
| EPS | -0.023 | -0.006 | -0.21 | 0.044 |
| % Growth | -303.4% | 97.2% | -575.1% | – |
| EPS Diluted | -0.023 | -0.006 | -0.21 | 0.044 |
| Weighted Avg Shares Out | 9,266 | 9,297 | 9,330 | 9,431 |
| Weighted Avg Shares Out Dil | 9,266 | 9,297 | 9,330 | 9,483 |
| Supplemental Information | – | – | – | – |
| Interest Income | $176 | $148 | $147 | $164 |
| Interest Expense | $275 | $269 | $211 | $117 |
| Depreciation & Amortization | $258 | $226 | $370 | $255 |
| EBITDA | $105 | $334 | -$1,542 | $932 |
| % Margin | 5.5% | 18% | -70.7% | 30.7% |